BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6211046)

  • 1. Determination of hCG in choriocarcinoma using RIA kits for hCG and hCG-beta.
    Vlachová J; Růzková M; Jakoubková J; Skrivan J; Zavadil M
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():166-71. PubMed ID: 6211046
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monitoring hCG and its subunits in patients with choriocarcinoma].
    Vlachová J; Skrivan J; RůzkováM ; Jakoubková J; Zavadil M; Polák J
    Cesk Gynekol; 1984 Sep; 49(8):559-63. PubMed ID: 6209023
    [No Abstract]   [Full Text] [Related]  

  • 3. The utility of radioimmunoassay of serum human chorionic gonadotropin in the management of choriocarcinoma.
    Gupta SK; Buckshee K; Talwar GP
    J Assoc Physicians India; 1985 Feb; 33(2):144-7. PubMed ID: 2581931
    [No Abstract]   [Full Text] [Related]  

  • 4. [The hook effect as a cause of falsely lowered beta-HCG values].
    Dahlmann N
    Dtsch Med Wochenschr; 1989 Jan; 114(1):36-7. PubMed ID: 2463141
    [No Abstract]   [Full Text] [Related]  

  • 5. HCG assays. A plea for uniformity.
    Bock JL
    Am J Clin Pathol; 1990 Mar; 93(3):432-3. PubMed ID: 1689949
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract]   [Full Text] [Related]  

  • 9. [Detection of hCG serum levels in choriocarcinoma using monoclonal antibodies].
    Vlachová J; Zavadil M; Jakoubková J; Skrivan J; Minajev G
    Cesk Gynekol; 1989 Apr; 54(3):179-84. PubMed ID: 2766368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and properties of a monoclonal antibody specific to the free beta-subunit of human chorionic gonadotropin (hCG beta) and its use in the isolation of free hCG beta produced by choriocarcinoma cells.
    Thotakura NR; Bahl OP
    Endocrinology; 1986 Nov; 119(5):1887-94. PubMed ID: 2429828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of epitopes associated with hCG and the beta hCG carboxyl terminus by monoclonal antibodies produced against a synthetic peptide.
    Bidart JM; Ozturk M; Bellet DH; Jolivet M; Gras-Masse H; Troalen F; Bohuon CJ; Wands JR
    J Immunol; 1985 Jan; 134(1):457-64. PubMed ID: 2578049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against beta-human chorionic gonadotropin. A comparative immunohistochemical study.
    Schaldenbrand J; Lloyd RV; Khazaeli MB
    Arch Pathol Lab Med; 1984 Sep; 108(9):704-6. PubMed ID: 6205635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
    Yuen BH; Cannon W; Benedet JL; Boyes DA
    Am J Obstet Gynecol; 1977 Apr; 127(7):711-2. PubMed ID: 557901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of pregnancy protein-1 (SP1) in the serum of a patient with beta-HCG negative choriocarcinoma].
    Göldel N; Eiermann W; Jehn U
    Med Klin (Munich); 1988 Jul; 83(15):490-1. PubMed ID: 2464123
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring of trophoblastic neoplasms through radioimmunoassay of the urinary carboxy-terminal fragment of beta-choriogonadotropin (COOH-beta-HCG-RIA).
    Ayala AR; González E; Castorena G; de Jesús Montoya J
    Arch Invest Med (Mex); 1984; 15(2):139-45. PubMed ID: 6207791
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-hCG vs intact hCG assays in the detection of trophoblastic disease.
    Rinker AD; Tietz NW
    Clin Chem; 1989 Aug; 35(8):1799-800. PubMed ID: 2474392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choriocarcinoma associated with undetectable levels of human chorionic gonadotropin.
    Lemonnier MC; Glezerman M; Vauclair R; Audet-Lapointe P
    Gynecol Oncol; 1986 Sep; 25(1):48-52. PubMed ID: 3732917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.